Britannia Statement on Carbon Footprint
Britannia Pharmaceuticals Ltd acknowledge that there is a pressing need to dramatically and urgently reduce global carbon emissions to prevent irreversible climate change. We are determined to play our part in this respect and reduce the carbon emissions attributable to our organisation.
Britannia have carried out a thorough and independent Carbon analysis of all activities attributable to our business. Baseline activities (2022) indicate less than 256 tCO2e are attributable to our operations, a reduction of 15% from 2019. We have also carried out a comprehensive analysis of Carbon emissions attributable to the organisations activities from 2017 to present day.
Britannia have already carried out some recent carbon reduction projects, which include; increased recycling throughout our head office, introduced motion censored lighting, site energy reduction, waste reduction and increased recycling. Going forward, we will also engage staff members to reduce their own Carbon emissions for and on behalf of the Company and personally, in their own lives. We will also investigate avenues to reduce emissions through available opportunities, including; embracing carbon reduction technologies and renewable energy generation usage.
We are committed to reduce our corporate carbon emissions even further by 2030
